Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis

Journal of Psychopharmacology

Volumn 28, Issue 6, 2014, Pages 553-560

  De Koning, Mariken B ^a,b   Bloemen, Oswald J N ^a   Van Duin, Esther D A ^a   Booij, Jan ^a   Abel, Kathryn M ^c   De Haan, Lieuwe ^a   Linszen, Don H ^a   Van Amelsvoort, Thérèse A M J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Arkin Mental Health Care   (Netherlands)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Acoustic startle response; biomarkers; dopamine; dopamine receptor; high risk; imaging; pre pulse inhibition; psychosis; schizophrenia; sensorimotor gating

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; IOLOPRIDE I 123; METIROSINE; 3-IODO-2-HYDROXY-6-METHOXY-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)BENZAMIDE; BENZAMIDE DERIVATIVE; CONTRAST MEDIUM; DRD2 PROTEIN, HUMAN; DRD3 PROTEIN, HUMAN; PYRROLIDINE DERIVATIVE;

ADULT; ARTICLE; AUDITORY RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE MARKER; FEMALE; HIGH RISK PATIENT; HUMAN; MALE; PATIENT ASSESSMENT; PREDICTION; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STARTLE REFLEX; SYNAPTIC POTENTIAL; SYNAPTIC TRANSMISSION; ADOLESCENT; AUDITORY STIMULATION; BASAL GANGLION; CASE CONTROL STUDY; DIAGNOSTIC IMAGING; DOPAMINERGIC NERVE CELL; METABOLISM; PATHOPHYSIOLOGY; PSYCHOLOGY; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; YOUNG ADULT;

ACOUSTIC STIMULATION; ADOLESCENT; ADULT; BASAL GANGLIA; BENZAMIDES; CASE-CONTROL STUDIES; CONTRAST MEDIA; DOPAMINE; DOPAMINERGIC NEURONS; FEMALE; HUMANS; MALE; PREPULSE INHIBITION; PSYCHOTIC DISORDERS; PYRROLIDINES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REFLEX, STARTLE; RISK ASSESSMENT; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YOUNG ADULT;

EID: 84901624540     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881113519507     Document Type: Article

References (40)

1. Abel K, Waikar M, Pedro B, et al. Repeated testing of prepulse inhibition and habituation of the startle reflex: A study in healthy human controls. J Psychopharmacol. 1998 ; 12: 330-337
2. Abi-Dargham A, Rodenhiser J, Printz D, et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA. 2000 ; 97: 8104-8109
3. Bitsios P, Giakoumaki SG, Frangou S. The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values. Psychopharmacology. 2005 ; 182: 144-152
4. Bloemen OJ, De Koning MB, Boot E, et al. Challenge and therapeutic studies using alpha-methyl-para-tyrosine (AMPT) in neuropsychiatric disorders: A review. CNS Agents Med Chem. 2008 ; 8: 249-256
5. Bloemen OJ, De Koning MB, Gleich T, et al. Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at ultra high risk for psychosis. Eur Neuropsychopharmacol. 2013 ; 23: 126-132
6. Braff D, Stone C, Callaway E, et al. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 1978 ; 15: 339-343
7. Braff DL, Grillon C, Geyer MA. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry. 1992 ; 49: 206-215
8. Cadenhead KS. Startle reactivity and prepulse inhibition in prodromal and early psychosis: Effects of age, antipsychotics, tobacco and Cannabis in a vulnerable population. Psychiatry Res. 2011 ; 188: 208-216
9. Cadenhead KS, Light GA, Geyer MA, et al. Neurobiological measures of schizotypal personality disorder: Defining an inhibitory endophenotype?. Am J Psychiatry. 2002 ; 159: 869-871
10. Cadenhead KS, Swerdlow NR, Shafer KM, et al. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: Evidence of inhibitory deficits. Am J Psychiatry. 2000 ; 157: 1660-1668
11. Canavan A, Dunn G, McMillan TM. Principal components of the WAIS-R. Brit J Clin Psychol. 1986 ; 25: 81-85
12. De Koning MB, Boot E, Bloemen OJ, et al. Startle reactivity and prepulse inhibition of the acoustic startle response are modulated by catechol-O-methyl-transferase Val158Met polymorphism in adults with 22q11 deletion syndrome. J Psychopharmacol. 2012 ; 26: 1548-1560
13. Egerton A, Chaddock CA, Winton-Brown TT, et al. Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: Findings in a second cohort. Biol Psychiatry. 2013 ; 74: 106-112
14. Giakoumaki SG, Roussos P, Bitsios P. Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism. Neuropsychopharmacol. 2008 ; 33: 3058-3068
15. Howes OD, Bose SK, Turkheimer F, et al. Dopamine synthesis capacity before onset of psychosis: A prospective [18F]-DOPA PET imaging study. Am J Psychiatry. 2011 ; 168: 1311-1317
16. Howes OD, Kambeitz J, Kim E, et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry. 2012 ; 69: 776-786
17. Howes OD, Montgomery AJ, Asselin MC, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry. 2009 ; 66: 13-20
18. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987 ; 13: 261-276
19. Klosterkotter J, Hellmich M, Steinmeyer EM, et al. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001 ; 58: 158-164
20. Kumari V, Gray JA. Smoking withdrawal, nicotine dependence and prepulse inhibition of the acoustic startle reflex. Psychopharmacol. 1999 ; 141: 11-15
21. McGowan S, Lawrence AD, Sales T, et al. Presynaptic dopaminergic dysfunction in schizophrenia: A positron emission tomographic [18F] fluorodopa study. Arch Gen Psychiatry. 2004 ; 61: 134-142
22. Miller TJ, McGlashan TH, Woods SW, et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Q. 1999 ; 70: 273-287
23. Quednow BB, Frommann I, Berning J, et al. Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia. Biol Psychiatry. 2008 ; 64: 766-773
24. Quednow BB, Wagner M, Westheide J, et al. Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine. Biol Psychiatry. 2006 ; 59: 536-545
25. Roussos P, Giakoumaki SG, Bitsios P. A risk PRODH haplotype affects sensorimotor gating, memory, schizotypy and anxiety in healthy male subjects. Biol Psychiatry. 2009a ; 65: 1063-1070
26. Roussos P, Giakoumaki SG, Bitsios P. Tolcapone effects on gating, working memory, and mood interact with the synonymous catechol-O-methyltransferase rs4818C/G polymorphism. Biol Psychiatry. 2009b ; 66: 997-1004
27. Schellekens AF, Grootens KP, Neef C, et al. Effect of apomorphine on cognitive performance and sensorimotor gating in humans. Psychopharmacol. 2010 ; 207: 559-569
28. Schmand B, Bakker D, Saan R, et al. The Dutch Reading Test for Adults: A measure of premorbid intelligence level. Tijdschr Gerontol Geriatr. 1991 ; 22: 15-19
29. Shotbolt P, Stokes PR, Owens SF, et al. Striatal dopamine synthesis capacity in twins discordant for schizophrenia. Psychol Med. 2011 ; 41: 2331-2338
30. Suridjan I, Rusjan P, Addington J, et al. Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls, while performing a cognitive task. J Psychiatry Neurosci. 2013 ; 38: 98-106
31. Swerdlow NR, Shoemaker JM, Bongiovanni MJ, et al. Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration. Pharmacol Biochem Behav. 2007 ; 87: 1-10
32. Swerdlow NR, Stephany N, Shoemaker JM, et al. Effects of amantadine and bromocriptine on startle and sensorimotor gating: Parametric studies and cross-species comparisons. Psychopharmacol. 2002 ; 164: 82-92
33. Swerdlow NR, Stephany N, Wasserman LC, et al. Amphetamine effects on prepulse inhibition across-species: Replication and parametric extension. Neuropsychopharmacol. 2003 ; 28: 640-650
34. Swerdlow NR, Weber M, Qu Y, et al. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacol. 2008 ; 199: 331-388
35. Turetsky BI, Calkins ME, Light GA, et al. Neurophysiological endophenotypes of schizophrenia: The viability of selected candidate measures. Schizophr Bull. 2007 ; 33: 69-94
36. Wechsler D Wechsler Adult Intelligence Scale Revised. New York: Psychological Corporation, Harcourt Brace ; 1987 :
37. Yung AR, Phillips LJ, Yuen HP, et al. Psychosis prediction: 12-Month follow up of a high-risk ('prodromal') group. Schizophr Res. 2003 ; 60: 21-32
38. Yung AR, Yuen HP, McGorry PD, et al. Mapping the onset of psychosis: The Comprehensive Assessment of At-Risk Mental States. Aust NZ J Psychiatry. 2005 ; 39: 964-971
39. Zavitsanou K, Cranney J, Richardson R. Dopamine antagonists in the orbital prefrontal cortex reduce prepulse inhibition of the acoustic startle reflex in the rat. Pharmacol Biochem Behav. 1999 ; 63: 55-61
40. Ziermans TB, Schothorst PF, Sprong M, et al. Reduced prepulse inhibition as an early vulnerability marker of the psychosis prodrome in adolescence. Schizophr Res. 2012 ; 134: 10-15